IL17A and autoimmune disease: Plasticity of IL-17 expressing cells (primarily Th17 cells) has been demonstrated previously in vivo in mouse models of autoimmune disease, particularly in chronic inflammatory conditions, or during pathogenic challenge [16], [17], [35].